Sr. Director - Counsel, Cell & Gene Therapy at Eli Lilly and Company

Boston, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Bachelor’s and Juris Doctorate Degree
Licensed to practice law in at least one of fifty states
7-10 years of relevant legal experience either practicing as a member of a law firm with a nationally-recognized practice in a relevant area of law, in house at a pharmaceutical or biotechnology company’s law department, or a combination of the two
Qualified applicants must be authorized to work in the United States on a full-time basis (Lilly will not provide support for or sponsor work authorization and/or visas for this role)
Candidates based in or willing to relocate to Boston, MA or Indianapolis, IN highly advantageous
Working knowledge and understanding of critical legal domains for innovative, multinational pharmaceutical companies, including, but not limited to: global product development, registration, and commercialization; FDA labeling and advertising requirements; the Anti-kickback Statute and its safe harbors; the False Claims Act; antitrust; unfair competition law; consumer protection; data rights and privacy; FTC commercial law; and business transactions

Responsibilities

Deliver strategic and solutions-oriented counsel to multidisciplinary teams supporting expanding cell and gene therapy portfolios
Advance novel genetic medicine programs targeting critical therapeutic areas with significant unmet medical needs
Provide dynamic legal support across the complete product development and commercialization continuum
Guide complex regulatory, commercial, and transactional matters spanning from early-stage research through post-market activities
Collaborate extensively with internal legal teams and business stakeholders to navigate evolving regulatory and commercial frameworks for advanced therapies
Support new assets, either therapeutics or diagnostics, as needed to support the continued growth and expansion of Neuroscience and Cell & Gene Therapy portfolios
Act as an enterprise resource connector, bringing together collaborators across legal and the business to accomplish strategic objectives

Skills

Cell and Gene Therapy

Genetic Medicines

Regulatory Law

Commercial Law

Transactional Law

Life Sciences Law

Vector-based Therapeutics

Personalized Medicine

Product Development

Commercialization

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free